Bellevue Life Sciences Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BLAC research report →
Price Chart
About the company
Bellevue Life Sciences Acquisition Corp. currently does not engage in substantial operational activities. Its core mission is to orchestrate a business combination, which could manifest as a merger, share exchange, asset acquisition, stock purchase, recapitalization, or reorganization, with one or more enterprises or organizations within the healthcare domain.
- CEO
- Kuk Hyoun Hwang
- IPO
- 2023
- HQ
- Bellevue, WA, US
Get TickerSpark's AI analysis on BLAC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $6.98M
- P/E
- -0.08
- PEG
- 0.00
- P/S
- 5.40
- P/B
- 0.01
- EV/EBITDA
- -1.15
- Div Yield
- 0.00%
- Gross Margin
- -98.82%
- Op Margin
- -933.75%
- Net Margin
- -836.91%
- ROE
- -16.47%
- ROIC
- -10.61%
Latest fiscal year · YoY change
- Revenue
- $2.91M+0.0%
- Gross Profit
- $592.90K+0.0%
- Op Income
- $-18,336,004
- Net Income
- $-28,888,361-1098.2%
- EPS
- $0.00+100.0%
- OCF Growth
- +100.0%
- FCF Growth
- +100.0%
- 52W High
- $13.40
- 52W Low
- $3.01
- 50D MA
- $10.74
- 200D MA
- $10.87
- Beta
- 0.53
- RSI (14)
- 13
- Avg Volume
- 15.26K
No earnings-call transcripts are available for BLAC yet.
- Free Float
- 99.6%
- Shares Outstanding
- 2.32M
- Float Shares
- 2.31M
of shares held by institutions
13 13F filers
Buy/sell ratio 0.56. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Exos Tfp Holdings LLC | 200.00K | 0 |
| Cowen And Company, LLC | 185.76K | ▼ 7.62K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 23, 23 | Yoo David Jin | other | 20,000 |
| Mar 23, 23 | Yoo David Jin | other | 20,000 |
| Feb 21, 23 | Hwang Kuk Hyoun | other | 225,000 |
| Feb 21, 23 | Hwang Kuk Hyoun | other | 4,500 |
| Feb 21, 23 | Bellevue Global Life Science Investors LLC | other | 225,000 |
| Feb 21, 23 | Bellevue Global Life Science Investors LLC | other | 4,500 |
| Feb 14, 23 | REED STEVEN | other | 20,000 |
| Feb 14, 23 | REED STEVEN | other | 20,000 |
| Feb 9, 23 | Yoo David Jin | other | 0 |
| Feb 9, 23 | REED STEVEN | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BLAC coverage
Recent articles, reports, and earnings notes.
No research on BLAC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BLAC report →Bellevue Life Sciences Acquisition (NASDAQ:BLAC) Shares Up 3.5% – Should You Buy?
defenseworld.net · Jan 15
Bellevue Life Sciences Acquisition (NASDAQ:BLAC) Stock Price Up 13.7% – Time to Buy?
defenseworld.net · Dec 24
Bellevue Life Sciences Acquisition Corp. Announces Approval of Business Combination Proposal And Name Change to OSR Holdings, Inc.
prnewswire.com · Feb 13
Bellevue Life Sciences Acquisitions Corp. Reminds Stockholders to Vote in Favor of Extension at May 14, 2024 Stockholder Meeting
prnewswire.com · May 13
OSR Holdings and SillaJen have entered into a Memorandum of Understanding to collaboratively pursue the development of innovative therapeutics and enter the U.S. market
prnewswire.com · Apr 22
OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp.
prnewswire.com · Nov 16
Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business Combination
prnewswire.com · Jul 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.